GlassScriptPhysician profile
Pavlo Isak
NPI 1922673276
$2,550.15
in general payments reported to CMS, 2019-2025
6 companies · $897 in 2025
The $897 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $1,251 · 2023: $38.16 · 2024: $77.96 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $652 · Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $651.60 |
| Food and Beverage | $361.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $855.65 | 2021-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Allergan, INC. | $752.85 | 2022 | |
| Tela Bio, INC. | $519.46 | 2021-2022 | |
| Abbvie INC. | $251.97 | 2024-2025 | |
| Smith+Nephew, INC. | $132.06 | 2022 | |
| Apollo Endosurgery US INC | $38.16 | 2023 | Orbera Intragastric Balloon System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavlo Isak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.